Dan Li
Direktor/Vorstandsmitglied bei ZHONGCHAO INC.
Vermögen: 3 000 $ am 31.05.2024
Aktive Positionen von Dan Li
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ZHONGCHAO INC. | Direktor/Vorstandsmitglied | 06.08.2019 | - |
Independent Dir/Board Member | 06.08.2019 | - |
Karriereverlauf von Dan Li
Ehemalige bekannte Positionen von Dan Li
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
EPS HOLDINGS, INC. | Corporate Officer/Principal | 01.10.2009 | 01.11.2011 |
Ausbildung von Dan Li
North China University of Science & Technology | Undergraduate Degree |
Peking University | Graduate Degree |
Keio University | Doctorate Degree |
Statistik
International
Japan | 3 |
China | 3 |
Cayman Islands | 2 |
Operativ
Director/Board Member | 1 |
Independent Dir/Board Member | 1 |
Undergraduate Degree | 1 |
Sektoral
Consumer Services | 4 |
Commercial Services | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ZHONGCHAO INC. | Commercial Services |
Private Unternehmen | 1 |
---|---|
EPS Holdings, Inc.
EPS Holdings, Inc. BiotechnologyHealth Technology EPS Holdings, Inc. engages in the drug development business. It operates through the following segments: Contract Research Organization (CRO), Site Management Organization (SMO), Contract Sales Organization (CSO), Global Research, Ekishin, and Others. The CRO segment offers clinical trials, data management, and statistical analysis. The SMO segment enters into contracts with medical institutions to conduct clinical trials. The CSO segment provides drug information and awareness for medical and pharmaceutical industries. The Global Research segment provides consignment services through its subsidiary for multilateral clinical trials in Asia-Pacific. The Ekishin segment focuses on medical equipment, pharmaceutical and investment related businesses through its Japan and China based subsidiaries. The Others segment provides various services related to management of clinical research from business processing outsource business related to medicine and medical care. The company was founded on May 30, 1991 and is headquartered in Tokyo, Japan. | Health Technology |